Company
Designing a Safer Future with Data With years of research expertise, ChemBAI is leading NAMs-based toxicity prediction technology and establishing new standards for science-based chemical safety management.
Building a Safe Ecosystem Through Data and Science
ChemBAI leverages AI and NAMs technology to scientifically predict chemical toxicity and hazards, presenting a new digital toxicity assessment paradigm that replaces animal testing.
Based on scientific reliability and explainability, we provide safety assessment solutions that both regulatory agencies and industries can utilize.
The NAMs Company
ChemBAI aspires to be "The NAMs Company," leading global standards in NAMs-based toxicity prediction. Through practical toxicity prediction solutions that regulatory agencies, companies, and researchers can use together, we realize human-centered safety and sustainable innovation.
Our Core Values
The Core Values That Drive ChemBAI
Scientific Reliability
Transparent and reproducible predictions based on data
Explainability
We visualize prediction results for universal understanding and clearly explain toxicity pathways based on AOP.
Sustainability
Meeting ESG and global regulatory requirements through responsible technology
Innovation for Safety
Developing technology for the safety of people and the environment
Collaboration and Openness
Achieving scalability through partnerships with public institutions, industries, and researchers
Our Journey
Company Milestones
Research Foundation & Technological Expertise
Over 20 Years of Integrated AI and Toxicology Research Foundation
Key R&D Achievements and Technology Development History (2002–Present)
Advancement of AOP-based mixture toxicity management and environmental disease prediction platform Leading the industrial and policy dissemination of NAMs-based integrated safety assessment technology and global standardization
Technology transfer from UOS Holdings. Initiated development of ToxBAI and ChemBAI NGRA, AI-NAMs integrated toxicity assessment platforms
Entered the commercialization phase of practical NAMs-based chemical safety management technology through the development of Integrated Testing Strategies (ITS/IATA) for mixture toxicity assessment of consumer chemical products based on AOP
Established data-driven toxicity assessment systems through environmental disease prediction model development and next-generation risk assessment strategy planning
Selected for Ministry of Environment "Top 20 Environmental Technology Development Achievements" (2025)
Expanded policy linkage of research outcomes through the Graduate School of Chemical Safety Management and Environmental Health Professional Training Program
Advanced NAMs and AOP technologies through inhalation toxicity AOP and alternative test method development, nano-ecotoxicity test method standardization, and integrated omics research
Selected for Ministry of Environment "Top 20 Environmental Technology Development Achievements" (2022)
Introduced NAMs (New Approach Methodologies) and AOP (Adverse Outcome Pathway)-based approaches Conducted R&D on alternative test methods for K-REACH compliance, nano-safety prediction research, and omics-based toxicity mechanism studies
Developed integrated toxicity assessment techniques for nanomaterials and indoor hazardous chemicals Conducted R&D on ecological and human health risk assessment systems
Established the Environmental Systems Toxicology Laboratory and built toxicity assessment methodologies Conducted R&D on environmental risk assessment and multi-stage biomarker development (National Research Foundation of Korea, Ministry of Environment)
Building on over 20 years of toxicity assessment research experience, we have developed scientific reliability and technological competitiveness through various national R&D projects, including nanomaterial hazard assessment and alternative test method (NAMs) development.
Based on these research achievements, ChemBAI Co., Ltd. was established in 2024 as a subsidiary through core technology transfer from UOS Holdings, and is now developing and disseminating smart chemical safety management solutions that integrate AI and NAMs technologies.
![켐바이 “AI·데이터로 화학물질 독성 예측…동물실험 없는 안전한 사회 꿈꾼다” [서울시립대학교 캠퍼스타운]](https://dimg.donga.com/wps/NEWS/IMAGE/2025/10/30/132667680.1.jpg)
Leadership Message
Hello, This is Jinhee Choi, CEO of ChemBAI
ChemBAI is an AI-powered toxicity prediction company dedicated to accurately and efficiently assessing the impact of chemicals on human health and the environment.
With over 20 years of toxicology research and national R&D achievements, we deliver NAMs (New Approach Methodologies)-based solutions that replace animal testing. Our explainable AI models, built on Adverse Outcome Pathways (AOP), provide both scientific rigor and practical value for policymakers and industry.
Chemical safety management is no longer optional—it's critical infrastructure for protecting public health and our industrial ecosystem. At ChemBAI, we're expanding the data-driven toxicity prediction ecosystem and building a global NAMs company grounded in scientific credibility and sustainability
Thank you.
Jinhee Choi
Founder & CEO
ChemBAI Co., Ltd.
Global Collaboration Network
Driving NAMs-based safety management innovation with research institutions and industry partners worldwide
Technology Holdings Partner
UOS Holdings
Building a Safer Future Together
Setting new standards for sustainable chemical safety management through AI and scientific evidence.